Affinity Asset Advisors, LLC Astrazeneca PLC Transaction History

Affinity Asset Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $4.88 Million - $6.34 Million	-90,000 Reduced 60.0%	60,000 $4.07 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $3.45 Million - $8.82 Million	65,000 Added 76.47%	150,000 $8.23 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $4.44 Million - $5.34 Million	-75,000 Reduced 46.88%	85,000 $5.62 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $8.92 Million - $10.7 Million	160,000 New	160,000 $10.6 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.